Anti-human olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomas

被引:120
作者
Yokoo, H
Nobusawa, S
Takebayashi, H
Ikenaka, K
Isoda, K
Kamiya, M
Sasaki, A
Hirato, J
Nakazato, Y
机构
[1] Gunma Univ, Grad Sch Med, Dept Pathol, Maebashi, Gumma 3718511, Japan
[2] Natl Inst Physiol Sci, Okazaki, Aichi, Japan
关键词
D O I
10.1016/S0002-9440(10)63730-3
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Olig2 is a recently identified transcription factor involved in the phenotype definition of cells in the oligodendroglial lineage. The expression of Olig2 transcript has been demonstrated in human oligodendroglial tumors, although the protein expression has not been studied extensively. We developed a polyclonal antibody to human Olig2 and analyzed it immunohistochemically. The antibody depicted a single distinct band of predicted molecular weight by Western blotting, and did not cross-react with human Olig1. in normal human brain tissue, the nuclei of oligodendrocytes of interfascicular, perivascular, and perineuronal disposition were clearly labeled by the antibody. Similarly, the nuclei of oligodendroglial tumors were labeled. There was no apparent correlation between the staining intensity and histological grade. Astrocytic components within the tumors were generally less or not stained. Astrocytic tumors were also positive with the Olig2 antiserum to a lesser extent, and the difference between oligodendroglial and astrocytic tumors was demonstrated by a statistical analysis. Olig2 and glial fibrillary acidic protein were expressed in a mutually exclusive manner, and Olig2 expression was cell-cycle related. Neither central neurocytoma nor schwannoma cases were stained. Our antibody was demonstrated to be useful in recognizing normal oligodendrocytes on paraffin sections, and applicable in diagnosis of some brain tumors.
引用
收藏
页码:1717 / 1725
页数:9
相关论文
共 40 条
[1]   Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells [J].
Bouvier, C ;
Bartoli, C ;
Aguirre-Cruz, L ;
Virard, I ;
Colin, C ;
Fernandez, C ;
Gouvernet, J ;
Figarella-Branger, D .
JOURNAL OF NEUROSURGERY, 2003, 99 (02) :344-350
[2]   The transcription factor Sox10 is a key regulator of peripheral glial development [J].
Britsch, S ;
Goerich, DE ;
Riethmacher, D ;
Peirano, RI ;
Rossner, M ;
Nave, KA ;
Birchmeier, C ;
Wegner, M .
GENES & DEVELOPMENT, 2001, 15 (01) :66-78
[3]   AGGRESSIVE OLIGODENDROGLIOMA - A CHEMOSENSITIVE TUMOR [J].
CAIRNCROSS, JG ;
GEORGE, ED ;
MACDONALD, DR ;
RAMSAY, DA .
NEUROSURGERY, 1992, 31 (01) :78-82
[4]   SUCCESSFUL CHEMOTHERAPY FOR RECURRENT MALIGNANT OLIGODENDROGLIOMA [J].
CAIRNCROSS, JG ;
MACDONALD, DR .
ANNALS OF NEUROLOGY, 1988, 23 (04) :360-364
[5]   The PEN5 epitope identifies an oligodendrocyte precursor cell population and pilocytic astrocytomas [J].
Figarella-Branger, D ;
Daniel, L ;
André, P ;
Guia, S ;
Renaud, W ;
Monti, G ;
Vivier, E ;
Rougon, G .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (04) :1261-1269
[6]  
Figarella-Branger D, 2000, CENTRAL NEUROCYTOMA, P107
[7]   Negative regulatory effect of an oligodendrocytic bHLH factor OLIG2 on the astrocytic differentiation pathway [J].
Fukuda, S ;
Kondo, T ;
Takebayashi, H ;
Taga, T .
CELL DEATH AND DIFFERENTIATION, 2004, 11 (02) :196-202
[8]   Glioblastomas with an oligodendroglial component: A pathological and molecular study [J].
He, J ;
Mokhtari, K ;
Sanson, M ;
Marie, Y ;
Kujas, M ;
Huguet, S ;
Leuraud, P ;
Capelle, L ;
Delattre, JY ;
Poirier, J ;
Hoang-Xuan, K .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (09) :863-871
[9]   OLIG-1 and 2 gene expression and oligodendroglial tumours [J].
Hoang-Xuan, K ;
Aguirre-Cruz, L ;
Mokhtari, K ;
Marie, Y ;
Sanson, M .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2002, 28 (02) :89-94
[10]   ANTIGENIC EXPRESSION BY CELLS DERIVED FROM HUMAN GLIOMAS DOES NOT CORRELATE WITH MORPHOLOGICAL CLASSIFICATION [J].
KENNEDY, PGE ;
WATKINS, BA ;
THOMAS, DGT ;
NOBLE, MD .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1987, 13 (05) :327-347